TREATMENT PERSISTENCE AMONG TREATMENT-EXPERIENCED PEOPLE WITH HIV (PWH) SWITCHING TO INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)-BASED HIV ANTIRETROVIRAL REGIMENS

被引：0
|
作者：
Chuo, C. Y. [1 ]
Christoph, M. J. [1 ]
Zachry, W. [1 ]
de Boer, M. [1 ]
Chen, M. [1 ]
Trom, C. [1 ]
机构：
[1] Gilead Sci Inc, Foster City, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR119
引用
收藏
页码：S318 / S318
页数：1
相关论文
共 50 条
  • [1] Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naive and Treatment-Experienced HIV Patients in South Korea
    Jeong, Wooyong
    Jung, In Young
    Choi, Heun
    Kim, Jung Ho
    Seong, Hye
    Ahn, Jin Young
    Jeong, Su Jin
    Ku, Nam Su
    Kim, June Myung
    Choi, Jun Yong
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2019, 35 (02) : 213 - 216
  • [2] Integrase Strand Transfer Inhibitor (INSTI) Genotypic Resistance Analysis in Treatment-Naive, INSTI Free Antiretroviral-Experienced and INSTI-Experienced Turkish Patients Infected with HIV-1
    Sayan, Murat
    Yildirim, Figen Sarigul
    Akhan, Sila
    Karaoglan, Ilkay
    Akalin, Halis
    CURRENT HIV RESEARCH, 2022, 20 (02) : 184 - 192
  • [3] Persistence in treatment-experienced people with HIV switching anti-retroviral therapy regimens since 2018
    Colson, Amy
    Chastek, Benjamin
    Gruber, Joshua
    Majethia, Sunil
    Zachry, Woodie
    Mezzio, Dylan
    Rock, Marvin
    Anderson, Amy
    Cohen, Joshua
    FUTURE VIROLOGY, 2024, 19 (10-11) : 371 - 380
  • [4] Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen
    Santoro, Maria M.
    Fornabaio, Chiara
    Malena, Marina
    Galli, Laura
    Poli, Andrea
    Menozzi, Marianna
    Zazzi, Maurizio
    White, Kirsten L.
    Castagna, Antonella
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
  • [5] Simplification to dual protease inhibitor (PI)-, integrase strand transfer inhibitor (INSTI)-and non-nucleoside reverse-transcriptase inhibitor (NNRTI)-based less drugs regimens in treatment-experienced HIV-1-infected patients
    Mastroianni, Antonio
    Briganti, Elisabetta
    Allegrini, Francesco
    Grosso, Carmela
    Brighi, Sandra
    Ravaglia, Gianfranco
    Pieraccini, Fabio
    Cancellieri, Claudio
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [6] Antiretroviral regimens for treatment-experienced patients with HIV-1 infection
    Lagnese, Meena
    Daar, Eric S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (05) : 687 - 700
  • [7] Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018
    Colson, Amy
    Chastek, Ben
    Gruber, Joshua
    Majethia, Sunil
    Zachry, Woodie
    Mezzio, Dylan
    Rock, Marvin
    Anderson, Amy
    Cohen, Joshua P.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (08): : 817 - 824
  • [8] Successful optimization of antiretroviral regimens in treatment-experienced people living with HIV undergoing liver transplantation
    Waldman, Georgina
    Rawlings, Stephen A.
    Kerr, Janice
    Vodkin, Irine
    Aslam, Saima
    Logan, Cathy
    Dan, Jennifer
    Mehta, Sanjay
    Hill, Lucas
    Karris, Maile Y.
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (06)
  • [9] Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe
    Rossetti, Barbara
    Fabbiani, Massimiliano
    Di Carlo, Domenico
    Incardona, Francesca
    Abecasis, Ana
    Gomes, Perpetua
    Geretti, Anna Maria
    Seguin-Devaux, Carole
    Garcia, Federico
    Kaiser, Rolf
    Modica, Sara
    Shallvari, Adrian
    Sonnerborg, Anders
    Zazzi, Maurizio
    HIV MEDICINE, 2022, 23 (07) : 774 - 789
  • [10] Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens
    Raffi, F.
    Esser, S.
    Nunnari, G.
    Perez-Valero, I.
    Waters, L.
    HIV MEDICINE, 2016, 17 : 3 - 16
12345